Phase I

One of every 10,000

substances that undergoes pharmaceutical research reaches the market.
We provide optimal support to ensure that your newly developed pharmaceutical product overcomes the steps required during the approval process.


has many years of experience in the planning, coordination, evaluation and creation of reports for pharmacokinetic and bioavailability studies.
Within Germany or internationally, we work with a broad spectrum of knowledge relating to the indication areas on a monocentric or multicentric basis.

Needless to say, all partners are audited according to ICH-GCP directives.

You have the choice: full service or partial service – we support you to meet your needs.